Tonix Pharmaceuticals Holding Corp. — Form 8-K
Filed October 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Tonix Pharmaceuticals filed a Form 8-K on October 2, 2026 (reporting period October 1, 2026). The filing contains only Item 8.01 (Other Events) with no substantive disclosures of counterparties, dollar amounts, share counts, or business developments. The specific nature of the 'other event' is not detailed in the document index or filing materials provided.
Why this rating
No material event disclosed; routine SEC compliance filing with no concrete business impact or financial substance.
Extracted items
See more from October 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.